HomeOwner SearchCategory Search
Visit USCOInternational Journal of Pharmaceutics [Published: 2017-09-21. Issue: vol. 531, no. 1, 5 October 2017]
Serial Registration
Copyright Title
International Journal of Pharmaceutics [Published: 2017-09-21. Issue: vol. 531, no. 1, 5 October 2017]
Status
Published
on 13 Oct 2017
Year of Creation
2017
Copyright Claimant
Elsevier
Registration Number
TX0008531652
on 13 Oct 2017Copyright Summary
The U.S. Copyright record (Registration Number: TX0008531652) dated 13 Oct 2017, pertains to an electronic file (eService) titled "International Journal of Pharmaceutics [Published: 2017-09-21. Issue: vol. 531, no. 1, 5 October 2017]" created in 2017. The copyright holder is Elsevier, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to Elsevier.
Application Details
Registration Number
TX0008531652
Registration Date
10/13/2017
Year of Creation
2017
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Elsevier
First Publication Nation
Netherlands
ISSN
0378-5173
Preexisting Material
Permissioned materials
Notes
Rights Note: permissions@elsevier.com
Copyright Local Holdings: vol. 531, no. 1, 5 October 2017 (C.O. correspondence) Created 2017 Pub. 2017-09-21 Reg. 2017-11-08 TX0008531652 KADA
Local Copyright Note: C.O. correspondence
Material Matter Claimed Note: compilation, editing, text, figures
Statements
Application Title Statement: International Journal of Pharmaceutics
Author Statement: Elsevier employer for hire Domicile: Netherlands Citizenship: Netherlands Authorship: compilation
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.